Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Operating Cash Flow per Share : ¥0.05 (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co Operating Cash Flow per Share?

Suzhou Zelgen Biopharmaceuticals Co's operating cash flow per share for the three months ended in Jun. 2024 was ¥0.09. Suzhou Zelgen Biopharmaceuticals Co's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:688266' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -15.5 Med: -0.45 Max: 14.6
Current: 14.6

During the past 8 years, Suzhou Zelgen Biopharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 14.60% per year. The lowest was -15.50% per year. And the median was -0.45% per year.

SHSE:688266's 3-Year OCF Growth Rate is ranked better than
60.81% of 1217 companies
in the Biotechnology industry
Industry Median: 3.6 vs SHSE:688266: 14.60

Suzhou Zelgen Biopharmaceuticals Co Operating Cash Flow per Share Historical Data

The historical data trend for Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Zelgen Biopharmaceuticals Co Operating Cash Flow per Share Chart

Suzhou Zelgen Biopharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.00

-1.47

-1.90

-1.55

-0.91

Suzhou Zelgen Biopharmaceuticals Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.40	-0.37	-0.01	0.34	0.09

Competitive Comparison of Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Suzhou Zelgen Biopharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Zelgen Biopharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Zelgen Biopharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Suzhou Zelgen Biopharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.

Suzhou Zelgen Biopharmaceuticals Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-232.751	/	255.580
	=	-0.91

Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	23.529	/	268.959
	=	0.09

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.05

Suzhou Zelgen Biopharmaceuticals Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Zelgen Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN

Website

http://www.zelgen.com

Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.

Executives

Zhang Bin	Core technical personnel
Huang Gang	senior management
Lv Bin Hua	Directors, senior managers, core technical personn
Lu Hui Ping	Directors, senior managers
Gao Qing Ping	senior management
Wu Ji Sheng	Directors, senior managers, core technical personn
Zhang Jun Li	senior management
Wu Li Qing	Core technical personnel
	Core technical personnel
Sheng Ze Lin	Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co Headlines

No Headlines